Advisory Services Network’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.62K | Buy |
+13
| New | +$3.74K | ﹤0.01% | 3971 |
|
|
2025
Q4 | – | Sell |
-85
| Closed | -$23.8K | – | 2076 |
|
|
2025
Q3 | $23.8K | Buy |
+85
| New | +$23.1K | ﹤0.01% | 2864 |
|
|
2024
Q2 | – | Sell |
-674
| Closed | -$233K | – | 1542 |
|
|
2024
Q1 | $233K | Buy |
674
+589
| +693% | +$194K | 0.01% | 1266 |
|
|
2023
Q4 | $27.4K | Buy |
+85
| New | +$26.6K | ﹤0.01% | 2344 |
|
|
2023
Q3 | – | Sell |
-1,921
| Closed | -$728K | – | 1481 |
|
|
2023
Q2 | $728K | Buy |
1,921
+1,826
| +1,922% | +$743K | 0.02% | 754 |
|
|
2023
Q1 | $45.5K | Buy |
95
+1
| +1% | +$468 | ﹤0.01% | 2073 |
|
|
2022
Q4 | $39.5K | Buy |
+94
| New | +$37.9K | ﹤0.01% | 2097 |
|
|
2022
Q2 | – | Sell |
-528
| Closed | -$296K | – | 1386 |
|
|
2022
Q1 | $296K | Sell |
528
-37
| -7% | -$22.3K | 0.01% | 1162 |
|
|
2021
Q4 | $427K | Buy |
565
+29
| +5% | +$21.7K | 0.01% | 942 |
|
|
2021
Q3 | $400K | Sell |
536
-1
| -0.2% | -$749 | 0.01% | 963 |
|
|
2021
Q2 | $346K | Buy |
+537
| New | +$327K | 0.01% | 1022 |
|
|
2021
Q1 | – | Sell |
-121
| Closed | -$71K | – | 1457 |
|
|
2020
Q4 | $71K | Sell |
121
-53
| -30% | -$30.2K | ﹤0.01% | 1495 |
|
|
2020
Q3 | $90K | Buy |
+174
| New | +$88.1K | ﹤0.01% | 1292 |
|
|
2020
Q2 | – | Sell |
-172
| Closed | -$60K | – | 1214 |
|
|
2020
Q1 | $60K | Sell |
172
-22
| -11% | -$8.09K | ﹤0.01% | 1293 |
|
|
2019
Q4 | $72K | Buy |
194
+34
| +21% | +$12K | ﹤0.01% | 1315 |
|
|
2019
Q3 | $50K | Hold |
160
| – | – | ﹤0.01% | 1361 |
|
|
2019
Q2 | $50K | Buy |
160
+63
| +65% | +$18.9K | ﹤0.01% | 1359 |
|
|
2019
Q1 | $30K | Sell |
97
-13
| -12% | -$3.51K | ﹤0.01% | 1431 |
|
|
2018
Q4 | $26K | Sell |
110
-70
| -39% | -$18.8K | ﹤0.01% | 1384 |
|
|
2018
Q3 | $56K | Sell |
180
-85
| -32% | -$26.4K | ﹤0.01% | 1178 |
|
|
2018
Q2 | $83K | Sell |
265
-753
| -74% | -$208K | 0.01% | 1019 |
|
|
2018
Q1 | $255K | Sell |
1,018
-199
| -16% | -$50.7K | 0.02% | 702 |
|
|
2017
Q4 | $290K | Buy |
1,217
+835
| +219% | +$202K | 0.03% | 651 |
|
|
2017
Q3 | $85K | Hold |
382
| – | – | 0.01% | 916 |
|
|
2017
Q2 | $86K | Sell |
382
-194
| -34% | -$42.3K | 0.01% | 887 |
|
|
2017
Q1 | $115K | Buy |
+576
| New | +$111K | 0.02% | 768 |
|
|
2016
Q3 | $1K | Buy |
+7
| New | +$1.06K | ﹤0.01% | 1853 |
|
Other funds holding BIO
VCM
VPM
AI
Advisory Services Network's BIO Position: Q1 2026 in Review
Advisory Services Network opened a new position in Bio-Rad Laboratories Class A (BIO) in Q1 2026: 13 shares worth $3.62K. The stake represents ﹤0.01% of the portfolio and ranks #3971 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in BIO as recently as Q3 2025.
Advisory Services Network first reported a position in BIO in Q3 2016 and has held it in 27 quarters since. The position peaked at $728K in Q2 2023. 391 funds tracked by Wall St. Rank hold BIO as of Q1 2026.
- Advisory Services Network held 13 shares of Bio-Rad Laboratories Class A worth $3.62K as of Q1 2026.
- Bio-Rad Laboratories Class A was a new Advisory Services Network position in Q1 2026.
- Bio-Rad Laboratories Class A made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3971 holding.
- Advisory Services Network first reported a position in Bio-Rad Laboratories Class A in Q3 2016 and has held it in 27 quarters since.
- Advisory Services Network's Bio-Rad Laboratories Class A position peaked at $728K in Q2 2023.
- 391 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.
Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.